The blend delivers 330 mcg per day (2,310 mcg per week on a 7-day schedule), which aligns with the lower end of maintenance dosing
However, 1-2% report symptoms consistent with low blood pressure, primarily dizziness upon standing, more commonly during the first 1-2 weeks as their body adjusts
Our guide on NAD and tirzepatide together covers the rationale and protocol considerations for this combination
Laboratory Research Contexts Researchers may investigate the BPC-157 & TB-500 Blend within experimental frameworks such as: Peptide interaction studies Molecular signaling pathway analysis Extracellular matrix and connective tissue research models Cellular peptide signaling investigations Peptide structure and stability studies BPC-157 & TB-500 Blend 20mg Research Supply Specifications Multi-peptide research formulation Total peptide content: 20mg lyophilized powder Composition: 10mg BPC-157 + 10mg TB-500 Analytical purity standard: 99%+ Third-party laboratory testing for identity and purity Manufactured under controlled quality standards Canada-based fulfillment Batch-level quality verification Purity & Quality Assurance ExoLabz provides research peptides manufactured to high analytical standards
Every vial is 99.9% HPLC-verified, shipped cold-chain from Canada, with a batch-specific purity report available on request.
Important distinction: "Legal to compound" under 503A is NOT the same as "FDA approved." An FDA-approved drug has gone through full clinical trials and received a New Drug Application (NDA) approval